Laurent Ducry, Ph.D (born 1971) studied chemistry at the University of Lausanne (Switzerland) and did his diploma thesis with Prof. T. Gallagher at the University of Bristol (UK). He obtained his Ph.D. from the ETH Zürich (Switzerland) with Prof. F. Diederich in 1998. During his graduate studies, he worked during six months with Dr. G. Olson at Hoffmann-La Roche in Nutley (New Jersey). He then held a Swiss National Science Foundation postdoctoral fellowship at the University of Pennsylvania in Philadelphia with Prof. A. B. Smith, III and Prof. R. Hirschmann.
Ducry began his industrial carrier in process R&D at Lonza in Visp (Switzerland) in 2000 and became project leader the following year. His activities focused on the development and scale-up of chemical processes, as well as the production of pharmaceutical intermediates and APIs under cGMP. In the second half of 2006 he trained the Lonza R&D team in Nansha (China) and was promoted Senior Research Associate in 2007. Since 2008, he is leading the antibody-drug conjugates R&D group of Lonza.
He is the editor of “Antibody-Drug Conjugates: Methods and Protocols” (Springer, Humana Press, 2013).
Last Editorial Review: March 15, 2015
Copyright © 2015 InPress Media Group. All rights reserved. Republication or redistribution of InPress Media Group content, including by framing or similar means, is expressly prohibited without the prior written consent of InPress Media Group. InPress Media Group shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. ADC Review / Journal of Antibody-drug Conjugates is a registered trademarks and trademarks of InPress Media Group around the world.